The role of calcium/calmodulin-dependent protein kinase cascade on MIP-1alpha gene expression of ATL cells

Exp Hematol. 2008 Apr;36(4):390-400. doi: 10.1016/j.exphem.2007.11.013. Epub 2008 Jan 30.

Abstract

Objective: Adult T-cell leukemia (ATL) is a mature CD4(+) T-cell malignancy caused by infection with human T-lymphotrophic virus type-1 and is associated with a marked hypercalcemia in many patients. Recently, it has been proposed that macrophage inflammatory protein-1alpha (MIP-1alpha) is the clinical hallmark of hypercalcemia in ATL. In this study, we investigated the effect of extracellular calcium on MIP-1alpha secretion in ATL cells and the role of Ca(2+)/calmodulin (CaM)-dependent protein kinase (CaM-K) cascade in transcriptional activation of MIP-1alpha.

Materials and methods: MIP-1alpha protein levels in the culture supernatant collected from ATL cells were measured by enzyme-linked immunosorbent assay. Reporter plasmid containing the MIP-1alpha promoter was transfected to ATL cells, and the promoter activity was measured by luciferase assay.

Results: The addition of calcium to the culture medium enhanced the secretion of MIP-1alpha from ATL cells, which was inhibited by the CaM-KK inhibitor. The transfection of CaM-KIV stimulated MIP-1alpha promoter activity, and the upstream kinase CaM-KK enhanced the stimulatory effect of CaM-KIV on the promoter activity. Mutation in the cyclic adenosine 5' monophosphate response element (CRE) within the MIP-1alpha promoter significantly reduced the effect of CaM-KIV, and CRE mutant promoter activity was not significantly enhanced by the addition of calcium to the culture medium as compared to wild-type promoter activity.

Conclusion: Hypercalcemia enhances MIP-1alpha secretion in ATL cells, and this mechanism requires the involvement of CaM-KK/CaM-KIV cascade through the CRE. These findings raise a possibility that the inhibitory effect of CaM-KK/CaM-KIV cascade may be a potential therapeutic target for ATL.

MeSH terms

  • Benzimidazoles / pharmacology
  • Calcium / pharmacology
  • Calcium-Calmodulin-Dependent Protein Kinase Kinase / antagonists & inhibitors
  • Calcium-Calmodulin-Dependent Protein Kinases / metabolism*
  • Cell Line, Tumor
  • Chemokine CCL3 / genetics
  • Chemokine CCL3 / metabolism*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Gene Expression Regulation, Leukemic / drug effects*
  • Humans
  • Isoquinolines / pharmacology
  • Leukemia, T-Cell / drug therapy
  • Leukemia, T-Cell / metabolism*
  • Naphthalimides / pharmacology
  • Phosphorylation / drug effects
  • Promoter Regions, Genetic
  • Signal Transduction / drug effects*

Substances

  • Benzimidazoles
  • Chemokine CCL3
  • Enzyme Inhibitors
  • Isoquinolines
  • Naphthalimides
  • STO 609
  • Calcium-Calmodulin-Dependent Protein Kinase Kinase
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Calcium